600079 人福医药
已收盘 07-24 15:00:00
资讯
新帖
简况
肝炎概念盘中拉升,人福医药涨0.67%
自选股智能写手 · 07-24 09:39
肝炎概念盘中拉升,人福医药涨0.67%
北向资金7月23日净买入人福医药76.63万股 连续3日增持
自选股智能写手 · 07-24 09:30
北向资金7月23日净买入人福医药76.63万股 连续3日增持
人福医药07月22日收涨0.27% 主力资金逆市抛售
自选股智能写手 · 07-22 15:17
人福医药07月22日收涨0.27% 主力资金逆市抛售
熊去氧胆酸概念盘中跳水,人福医药跌0.11%
自选股智能写手 · 07-19
熊去氧胆酸概念盘中跳水,人福医药跌0.11%
人福医药07月15日主力资金流入880万元 连续3日加仓
自选股智能写手 · 07-15
人福医药07月15日主力资金流入880万元 连续3日加仓
生物疫苗概念盘中跳水,人福医药跌0.06%
自选股智能写手 · 07-15
生物疫苗概念盘中跳水,人福医药跌0.06%
人福医药: 2023年度公司硫酸新霉素原料药销售收入约2.1亿元
证星董秘互动 · 07-12
人福医药: 2023年度公司硫酸新霉素原料药销售收入约2.1亿元
人福医药(600079.SH):磷酸奥司他韦胶囊获得药品注册证书
格隆汇资讯 · 07-10
人福医药(600079.SH):磷酸奥司他韦胶囊获得药品注册证书
人福医药最新公告:磷酸奥司他韦胶囊获得药品注册证书
证券之星 · 07-10
人福医药最新公告:磷酸奥司他韦胶囊获得药品注册证书
人福医药(600079.SH):“帕拉米韦注射液”获批注册
智通财经 · 07-08
人福医药(600079.SH):“帕拉米韦注射液”获批注册
人福医药:产品取得注册证
每日经济新闻 · 07-08
人福医药:产品取得注册证
人福医药最新公告:帕拉米韦注射液获得药品注册证书
证券之星 · 07-08
人福医药最新公告:帕拉米韦注射液获得药品注册证书
北向资金7月5日净买入人福医药20.84万股 连续3日增持
自选股智能写手 · 07-08
北向资金7月5日净买入人福医药20.84万股 连续3日增持
人福医药7月15日解禁58.35万股,市值约997.78万元
金融界 · 07-08
人福医药7月15日解禁58.35万股,市值约997.78万元
华夏银行: 武汉当代科技产业集团股份有限公司以其持有的人福医药集团股份公司流通股在我行作质押融资
证券之星 · 07-05
华夏银行: 武汉当代科技产业集团股份有限公司以其持有的人福医药集团股份公司流通股在我行作质押融资
7月5日人福医药涨7.21%,鹏华匠心精选混合A基金重仓该股
证券之星 · 07-05
7月5日人福医药涨7.21%,鹏华匠心精选混合A基金重仓该股
人福医药大幅上涨 获北向资金增持100.91万股
智选洞察 · 07-05
人福医药大幅上涨 获北向资金增持100.91万股
熊去氧胆酸概念盘中拉升,人福医药涨4.08%
自选股智能写手 · 07-05
熊去氧胆酸概念盘中拉升,人福医药涨4.08%
病毒防治概念盘中拉升,天瑞仪器涨8.41%
自选股智能写手 · 07-05
病毒防治概念盘中拉升,天瑞仪器涨8.41%
人福医药大跌5.14% 创近1年新低
智选洞察 · 07-04
人福医药大跌5.14% 创近1年新低
加载更多
公司概况
公司名称:
人福医药集团股份公司
所属行业:
医药制造业
上市日期:
1997-06-06
主营业务:
人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械。公司坚持实施国际化战略,面向全球医药市场进行产业布局,海外业务现已覆盖了欧美成熟市场以及南美、东南亚、中亚、西非、东非等新兴市场。
发行价格:
5.22
{"stockData":{"symbol":"600079","market":"SH","secType":"STK","nameCN":"人福医药","latestPrice":18.19,"timestamp":1721804400000,"preClose":17.82,"halted":0,"volume":12368910,"delay":0,"floatShares":1537000000,"shares":1632000000,"eps":1.1981,"marketStatus":"已收盘","marketStatusCode":5,"change":0.37,"latestTime":"07-24 15:00:00","open":17.8,"high":18.27,"low":17.77,"amount":224000000,"amplitude":0.0281,"askPrice":18.19,"askSize":67,"bidPrice":18.18,"bidSize":13,"shortable":0,"etf":0,"ttmEps":1.1981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721871000000},"adr":0,"adjPreClose":17.82,"symbolType":"stock","openAndCloseTimeList":[[1721784600000,1721791800000],[1721797200000,1721804400000]],"highLimit":19.6,"lowLimit":16.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1632257765,"pbRate":1.7,"roa":"--","roe":"2.82%","epsLYR":1.32,"committee":0.090188,"marketValue":29691000000,"floatMarketCap":27956000000,"peRate":15.182372,"changeRate":0.0208,"turnoverRate":0.008,"status":0},"requestUrl":"/m/hq/s/600079","defaultTab":"news","newsList":[{"id":"2453014694","title":"肝炎概念盘中拉升,人福医药涨0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453014694","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453014694?lang=zh_cn&edition=full","pubTime":"2024-07-24 09:39","pubTimestamp":1721785174,"startTime":"0","endTime":"0","summary":"07月24日,肝炎概念盘中拉升,截至09点39分,肝炎概念整体指数上涨0.56%,报733.540点。从个股上来看,该概念的成分股中,人福医药涨0.67%,葵花药业、哈药股份、健帆生物涨幅居前。从资金上来看,截止发稿,肝炎概念概念主力净流入为-1812.77万,其中科伦药业受到资金热捧,主力净流入344.03万;拉长时间线来看,该板块近20日主力资金净流入-18.07亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724093934af93c39e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724093934af93c39e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0012","BK0239","BK0070","BK0028","BK0185","BK0188","BK0096"],"gpt_icon":0},{"id":"2453019501","title":"北向资金7月23日净买入人福医药76.63万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453019501","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453019501?lang=zh_cn&edition=full","pubTime":"2024-07-24 09:30","pubTimestamp":1721784606,"startTime":"0","endTime":"0","summary":"7月23日, 北向资金增持人福医药76.63万股,连续3日增持。截止当日收盘,沪股通共持有人福医药4105.08万股,占流通股2.67%。沪股通增持金额前五个股分别为寒武纪-U、农业银行、工商银行、工业富联、海光信息。人福医药近5个交易日上涨0.79%,沪股通累计增持116.74万股;近20个交易日上涨2.41%,沪股通累计减持428.93万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240930189ee41b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240930189ee41b28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0012","BK0239","BK0070","BK0028","BK0185","BK0188","BK0096"],"gpt_icon":0},{"id":"2453737558","title":"人福医药07月22日收涨0.27% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2453737558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453737558?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:17","pubTimestamp":1721632662,"startTime":"0","endTime":"0","summary":"07月22日, 人福医药股价涨0.27%,报收18.39元,成交金额1.77亿元,换手率0.63%,振幅2.18%,量比0.69。人福医药今日主力资金净流出3640万元,上一交易日主力净流出354万元,今日环比增加928.25%。该股近5个交易日上涨4.55%,主力资金累计净流出6836万元;近20日主力资金累计净流出1.74亿元,其中净流出天数为11日。该股主力净额占比0.13%,A股市场排名4783/5000,低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072215194995e77213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072215194995e77213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0012","600079","BK0239","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2452897496","title":"熊去氧胆酸概念盘中跳水,人福医药跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452897496","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452897496?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:58","pubTimestamp":1721354317,"startTime":"0","endTime":"0","summary":"07月19日,熊去氧胆酸概念盘中跳水,截至09点58分,熊去氧胆酸概念整体指数下跌0.51%,报871.830点。从个股上来看,该概念的成分股中,人福医药跌0.11%,跌幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-2968.56万,其中千红制药受到资金热捧,主力净流入393.28万;拉长时间线来看,该板块近20日主力资金净流入-10.37亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190958379681e3f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190958379681e3f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0239","BK0028","BK0070","BK0012","BK0185","600079","BK0188"],"gpt_icon":0},{"id":"2451694753","title":"人福医药07月15日主力资金流入880万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2451694753","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451694753?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:17","pubTimestamp":1721027839,"startTime":"0","endTime":"0","summary":"07月15日, 人福医药股价涨1.97%,报收17.59元,成交金额2.74亿元,换手率1.02%,振幅3.83%,量比1.23。人福医药今日主力资金净流入880万元,连续3日净流入,上一交易日主力净流入561万元,今日环比增加56.86%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为46.67%,平均涨幅为0.87%。该股近5个交易日上涨5.96%,主力资金累计净流出154万元;近20日主力资金累计净流出1.75亿元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515182395bed087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515182395bed087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0239","600079","BK0188","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2451179650","title":"生物疫苗概念盘中跳水,人福医药跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451179650","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451179650?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:50","pubTimestamp":1721008234,"startTime":"0","endTime":"0","summary":"07月15日,生物疫苗概念盘中跳水,截至09点50分,生物疫苗概念整体指数下跌1.02%,报1681.510点。从个股上来看,该概念的成分股中,人福医药跌0.06%,跌幅居前。从资金上来看,截止发稿,生物疫苗概念主力净流入为-7085.00万,其中天康生物受到资金热捧,主力净流入990.48万;拉长时间线来看,该板块近20日主力资金净流入-19.65亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715095034941f6e27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715095034941f6e27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","159657","BK0188","BK0028","BK0070","BK0012","BK0239","BK0185","BK0096"],"gpt_icon":0},{"id":"2450307340","title":"人福医药: 2023年度公司硫酸新霉素原料药销售收入约2.1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450307340","media":"证星董秘互动","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450307340?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:06","pubTimestamp":1720778812,"startTime":"0","endTime":"0","summary":"2024年第一季度公司管理费用较去年同期有所增长,主要系本期较上年同期员工人数增长以及员工薪酬发生周期性调整,同时公司自2024年起执行分季度计提成长共享奖金所致。关于公司2024年半年度业绩情况请关注公司公告。2023年度公司硫酸新霉素原料药销售收入约2.1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071218111395acae44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071218111395acae44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0239","600079","BK0188","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2450586102","title":"人福医药(600079.SH):磷酸奥司他韦胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2450586102","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450586102?lang=zh_cn&edition=full","pubTime":"2024-07-10 18:01","pubTimestamp":1720605703,"startTime":"0","endTime":"0","summary":"格隆汇7月10日丨人福医药(600079.SH)公布,公司控股子公司宜昌人福药业有限责任公司(称“宜昌人福”,公司持有其80%的股权)近日收到国家药品监督管理局核准签发的磷酸奥司他韦胶囊的《药品注册证书》。磷酸奥司他韦胶囊为抗病毒药物,其适应症为用于成人和1岁及1岁以上儿童的甲型和乙型流感治疗(磷酸奥司他韦能够有效治疗甲型和乙型流感,但是乙型流感的临床应用数据尚不多),患者应在首次出现症状48小时以内使用;用于成人和13岁及13岁以上青少年的甲型和乙型流感的预防。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710180300959dff0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710180300959dff0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0012","BK0028","BK0188","BK0070","BK0239","BK0185","600079"],"gpt_icon":0},{"id":"2450619298","title":"人福医药最新公告:磷酸奥司他韦胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2450619298","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450619298?lang=zh_cn&edition=full","pubTime":"2024-07-10 18:00","pubTimestamp":1720605619,"startTime":"0","endTime":"0","summary":"人福医药公告,控股子公司宜昌人福药业有限责任公司近日收到国家药品监督管理局核准签发的磷酸奥司他韦胶囊的《药品注册证书》。磷酸奥司他韦胶囊为抗病毒药物,其适应症为用于成人和1岁及1岁以上儿童的甲型和乙型流感治疗,患者应在首次出现症状48小时以内使用;用于成人和13岁及13岁以上青少年的甲型和乙型流感的预防。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000037997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0012","BK0188","BK0096","BK0239","BK0185","600079","BK0028"],"gpt_icon":0},{"id":"2449779422","title":"人福医药(600079.SH):“帕拉米韦注射液”获批注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2449779422","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449779422?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:46","pubTimestamp":1720439184,"startTime":"0","endTime":"0","summary":"智通财经APP讯,人福医药(600079.SH)公告,公司控股子公司武汉人福利康药业有限公司(“人福利康”,公司及全资子公司持有其70.28%的股权,根据增资协议的远期回购约定,公司持有其100%权益)近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。据悉,帕拉米韦注射液用于治疗甲型或乙型流行性感冒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0028","BK0239","600079","BK0188","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2449977511","title":"人福医药:产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2449977511","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449977511?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:56","pubTimestamp":1720436207,"startTime":"0","endTime":"0","summary":"每经AI快讯,人福医药 7月8日晚间发布公告称,人福医药集团股份公司控股子公司武汉人福利康药业有限公司近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。产品名称为“帕拉米韦注射液”。2023年1至12月份,人福医药的营业收入构成为:医药占比53.05%,医药批发及相关业占比46.05%。截至发稿,人福医药市值为271亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081857309f1e374a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0239","600079","BK0188","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2449778109","title":"人福医药最新公告:帕拉米韦注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449778109","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449778109?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:40","pubTimestamp":1720435234,"startTime":"0","endTime":"0","summary":"人福医药公告,控股子公司人福利康近日收到国家药品监督管理局核准签发的帕拉米韦注射液的《药品注册证书》。帕拉米韦注射液用于治疗甲型或乙型流行性感冒。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","BK0239","BK0012","BK0028","600079","BK0096","BK0185"],"gpt_icon":0},{"id":"2449379770","title":"北向资金7月5日净买入人福医药20.84万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449379770","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449379770?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:30","pubTimestamp":1720402207,"startTime":"0","endTime":"0","summary":"7月5日, 北向资金增持人福医药20.84万股,连续3日增持。截止当日收盘,沪股通共持有人福医药4266.05万股,占流通股2.77%。沪股通增持金额前五个股分别为国投电力、中金黄金、中国核电、川投能源、中国石油。人福医药近5个交易日下跌0.41%,沪股通累计减持59.83万股;近20个交易日下跌10.61%,沪股通累计减持681.18万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708093020958d22b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708093020958d22b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0250","BK0070","BK0012","600079","BK0019","BK0096","BK0025","BK0239","000159","BK0028","BK0188","BK0029","BK0185"],"gpt_icon":0},{"id":"2449979733","title":"人福医药7月15日解禁58.35万股,市值约997.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449979733","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449979733?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:14","pubTimestamp":1720401253,"startTime":"0","endTime":"0","summary":"7月8日,巨灵财经数据显示,人福医药预计7月15日解禁限售股58.35万股,解禁类型为股权激励限售股份,本次解禁占解禁前流通市值比例为0.04%,解禁部分市值为997.78万元。截至前一交易日收盘,人福医药报17.10元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708091415958d0d43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708091415958d0d43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0185","BK0012","BK0096","BK0028","BK0239","600079","BK0188"],"gpt_icon":0},{"id":"2449263516","title":"华夏银行:\n武汉当代科技产业集团股份有限公司以其持有的人福医药集团股份公司流通股在我行作质押融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2449263516","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449263516?lang=zh_cn&edition=full","pubTime":"2024-07-05 19:02","pubTimestamp":1720177346,"startTime":"0","endTime":"0","summary":"证券之星消息,华夏银行07月05日在投资者关系平台上答复投资者关心的问题。投资者:武汉当代科技集团股份有限公司将5000万股人福医药股份质押给华夏银行股份有限公司武汉分行用于补充流动资金,在质押的股票足以覆盖欠款金额的情况下,为何不将相关股票法拍?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500040604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0070","SGXZ81163826.USD","BK0183","600079","BK0188","BK0278","BK0239","SGXZ49509284.SGD","BK0015","BK0028","BK0187","BK0185","600015","BK0096"],"gpt_icon":0},{"id":"2449125393","title":"7月5日人福医药涨7.21%,鹏华匠心精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449125393","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449125393?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:13","pubTimestamp":1720167224,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日人福医药涨7.21%,收盘报17.1元,换手率1.44%,成交量22.1万手,成交额3.66亿元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共100家,其中持有数量最多的公募基金为鹏华匠心精选混合A。鹏华匠心精选混合A目前规模为74.21亿元,最新净值0.677,较上一交易日下跌0.31%,近一年下跌7.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051615249f0935ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051615249f0935ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0012","BK0239","BK0070","BK0028","BK0185","BK0188","BK0096"],"gpt_icon":0},{"id":"2449623509","title":"人福医药大幅上涨 获北向资金增持100.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449623509","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449623509?lang=zh_cn&edition=full","pubTime":"2024-07-05 13:50","pubTimestamp":1720158627,"startTime":"0","endTime":"0","summary":"07月05日,人福医药股价大幅上涨,截至13点50分,人福医药上涨5.02%,报16.75元/股,成交2.16亿元,换手率0.86%,振幅5.14%。资金动向截止发稿,人福医药获得主力净流出335万元,其中超大单流出595万元,大单流入261万元。北向资金方面,人福医药07月04日获得北向资金增持100.91万股,截至07月04日,北向资金当前共持有人福医药4245.21万股,市值7.11亿元,持股占流通股比为2.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705135048af90b08c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705135048af90b08c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600079","BK0012","BK0096","BK0239","BK0028","BK0188","BK0185"],"gpt_icon":0},{"id":"2449331532","title":"熊去氧胆酸概念盘中拉升,人福医药涨4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449331532","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449331532?lang=zh_cn&edition=full","pubTime":"2024-07-05 13:40","pubTimestamp":1720158042,"startTime":"0","endTime":"0","summary":"07月05日,熊去氧胆酸概念盘中拉升,截至13点40分,熊去氧胆酸概念整体指数上涨2.01%,报863.730点。从个股上来看,该概念的成分股中,人福医药涨4.08%,千红制药、科伦药业、吉贝尔涨幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-2332.08万,其中九典制药受到资金热捧,主力净流入342.69万;拉长时间线来看,该板块近20日主力资金净流入-14.08亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705134042aef813a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705134042aef813a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0012","600079","BK0239","BK0070","BK0096","BK0185"],"gpt_icon":0},{"id":"2449288271","title":"病毒防治概念盘中拉升,天瑞仪器涨8.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449288271","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449288271?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:46","pubTimestamp":1720143989,"startTime":"0","endTime":"0","summary":"07月05日,病毒防治概念盘中拉升,截至09点46分,病毒防治概念整体指数上涨0.64%,报678.310点。从个股上来看,该概念的成分股中,天瑞仪器涨8.41%,罗欣药业、博拓生物、人福医药涨幅居前。从资金上来看,截止发稿,病毒防治概念主力净流入为-1.32亿,其中人福医药受到资金热捧,主力净流入535.59万;拉长时间线来看,该板块近20日主力资金净流入-80.63亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070509462996819b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070509462996819b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300165","600079","BK0159","BK0239","BK0096","BK0102","BK0150","BK0028","BK0070","BK0185","BK0225","BK0188","BK0012","BK0045"],"gpt_icon":0},{"id":"2448993474","title":"人福医药大跌5.14% 创近1年新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2448993474","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448993474?lang=zh_cn&edition=full","pubTime":"2024-07-04 13:07","pubTimestamp":1720069651,"startTime":"0","endTime":"0","summary":"07月04日,人福医药股价大幅下跌,截至13点07分,人福医药下跌5.14%,报15.70元/股,创近1年新低,成交2.57亿元,换手率1.04%,振幅5.50%。北向资金方面,人福医药07月03日获得北向资金增持35.96万股,截至07月03日,北向资金当前共持有人福医药4144.30万股,市值6.51亿元,持股占流通股比为2.69%。最新财报显示,今年一季报,人福医药实现营业收入63.67亿元,同比增长2.28%,净利润为4.86亿元,同比减少26.89%,基本每股收益为0.30元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704130756af907fa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704130756af907fa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0012","BK0239","BK0070","BK0028","BK0185","BK0188","BK0096"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-06-06","address":"湖北省武汉市洪山区东湖高新区高新大道666号","stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":0.0396},{"period":"3month","weight":-0.1009},{"period":"6month","weight":-0.1761},{"period":"1year","weight":-0.2586},{"period":"ytd","weight":-0.264}],"companyName":"人福医药集团股份公司","boardCode":"AI0027","perCapita":"30148股","boardName":"医药制造业","registeredCapital":"163225万元","compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0425},{"period":"6month","weight":0.0032},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.02}],"survey":" 人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械。公司坚持实施国际化战略,面向全球医药市场进行产业布局,海外业务现已覆盖了欧美成熟市场以及南美、东南亚、中亚、西非、东非等新兴市场。","serverTime":1721837794141,"listedPrice":5.22,"stockholders":"50977人(较上一季度增加24.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"人福医药,600079,人福医药股票,人福医药股票老虎,人福医药股票老虎国际,人福医药行情,人福医药股票行情,人福医药股价,人福医药股市,人福医药股票价格,人福医药股票交易,人福医药股票购买,人福医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}